1-3 of 3
Liza Knez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BONE Marrow Stromal CELL Paracrine Factors from PMF Patients, but NOT Healthy Donors, Protect JAK2 V617F CELLS from Ruxotinib-Induced Apoptosis

Free
Taghi Manshouri, PhD, Zeev Estrov, MD, Liza Knez, BSC, Ying Zhang, Ksenija Bozinovic, Vilma Dembitz, MD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1872.
https://doi.org/10.1182/blood.V124.21.1872.1872
Published: 2014
Journal Articles

Ruxolitinib, a Janus Kinase (JAK)-1 and -2 Inhibitor Modulates Microrna (miR) Levels in Patients with Myelofibrosis (MF): miR Levels Might Predict MF Treatment Outcome

Free
Taghi Manshouri, PhD, Zeev Estrov, Liza Knez, Ying Zhang, Ross L Levine, MD, Hagop M. Kantarjian, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1744.
https://doi.org/10.1182/blood.V118.21.1744.1744
Published: 2011
Journal Articles

Bone Marrow Stroma-Mediated Paracrine Inhibition of Ruxolitinib (INCB018424) Induced Apoptosis of JAK2 V617F -Mutated Cells

Free
Taghi Manshouri, PhD, Alfonso Quintás-Cardama, MD, Zeev Estrov, MD, Liza Knez, Ying Zhang, Hagop Kantarjian, MD, Srdan Verstovsek, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1976.
https://doi.org/10.1182/blood.V116.21.1976.1976
Published: 2010